Dr. Ahmed Abdalhadi graduated from the Islamic University of Gaza, Palestine, in 2014, with a degree in medicine. In 2017, he joined the Internal Medicine Residency Program at Hamad Medical Corporation (HMC) in Qatar through the Amiri Scholarship. He completed his residency in 2021.
He then started a Fellowship in Medical Oncology at HMC, which he finished in 2024. During his training, he received the Arab Board Certification in Internal Medicine in 2022. In 2023, he also earned Membership of the Royal Colleges of Physicians (MRCP) in both General Medicine and Medical Oncology. That same year, he was chosen to serve as Chief Fellow in Oncology.
Dr. Abdalhadi now specializes in Medical Oncology, focusing on the treatment of breast and gastrointestinal (GI) cancers. He is also actively involved in oncology research and medical education.
